Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

Recruiting now · Not applicable

Conditions studied: Breast Neoplasms, Chemotherapy-induced Peripheral Neuropathy

In brief

Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.

Key facts

Study ID

NCT05904340

Run by

National Taipei University of Nursing and Health Sciences

People needed

86

Starts

2023-07-01

Expected to finish

2025-04-30

Last updated by the study team

2024-11-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary diagnosed with breast cancer for the first time by a physician.
• Patients who have completed chemotherapy or postoperative adjuvant chemotherapy within 3 months, and the chemotherapy drugs used are paclitaxel, vinblastine or platinum drugs.
• Patients who have been evaluated by doctors as peripheral neuropathy caused by chemotherapy, and whose symptoms persist after completing chemotherapy.
• Peripheral sensory or peripheral motor neuropathy grade ≥ 2 in general toxicity criteria (NCI-CTCAE).
• Those who have clear consciousness and can communicate in Mandarin or Taiwanese.

You may not qualify if…

• Patients suffering from carcinoma in situ.
• Patients suffering from stage IV cancer.
• Patients suffering from metastatic cancer.
• Patients receiving peripheral neuropathy drugs (Duloxetine)
• Patients receiving acupoint stimulation therapy.
• Patients who are allergic to silicone patches.
• Patients with cardiac pacemakers.
• Patients suffering from diabetic peripheral neuropathy.
• Patients suffering from peripheral neuropathy of acquired immunodeficiency syndrome.
• Patients receiving treatment for mental illness.

Where it is running

• Changhua Christian Hospital — Changhua, Changhua, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.